Stay updated on Pembrolizumab for ALL MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Page updated to version v3.2.0 and now includes a government operations status notice; older version tag v3.1.0 was removed.
    Difference
    3%
    Check dated 2025-10-13T07:28:57.000Z thumbnail image
  2. Check
    20 days ago
    Change Detected
    Summary
    - Added new broader topics on lymphomas and virus infections, and updated revision to v3.1.0. - Removed two specific leukemia-related items and an older revision tag (v3.0.2).
    Difference
    2%
    Check dated 2025-09-29T03:10:18.000Z thumbnail image
  3. Check
    27 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:26:08.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T16:45:38.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The web page has added significant medical content related to acute lymphoblastic leukemia and its treatment, including specific diseases and a new drug, pembrolizumab, while removing various related topics and location details.
    Difference
    4%
    Check dated 2025-08-31T12:02:58.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.6%
    Check dated 2025-08-17T04:34:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.